Advanced search
Publication Cover
Current Medical Research and Opinion Volume 33, 2017 - Issue 6
Submit an article Journal homepage
731
Views
4
CrossRef citations to date
0
Altmetric
Diabetes

Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates

Agata SchubertJanssen-Cilag Poland, Warsaw, Poland; Correspondence[email protected]
,
Anders T. BuchholtJanssen-Cilag A/S, Birkerød, Denmark;
,
Antoine C. El KhouryJanssen-Cilag, Dubai, UAE;
,
Ahmed KamalJanssen-Cilag, Dubai, UAE;
&
Vanessa TaiebAmaris, London, UK
Pages 1155-1163 | Received 10 Nov 2016, Accepted 14 Mar 2017, Published online: 28 Apr 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Islam Eljilany, Faris El-Dahiyat, Louise Elizabeth Curley & Zaheer-Ud-Din Babar. (2018) Evaluating quantity and quality of literature focusing on health economics and pharmacoeconomics in Gulf Cooperation Council countries. Expert Review of Pharmacoeconomics & Outcomes Research 18:4, pages 403-414.
Read now

Articles from other publishers (3)

Mazhar Hussain, Asim Elahi, Javed Iqbal, Muhammad Ghafoor, Habib Rehman & Shoaib Akhtar. (2021) Comparison of Efficacy and Safety Profile of Sodium-Glucose Cotransporter-2 Inhibitors as Add-On Therapy in Patients With Type 2 Diabetes. Cureus.
Crossref
Rong‐Xing Liu, Yan Ma, Xue‐Lian Hu, Yun‐Peng Liao, Xiang‐Nan Hu, Bai‐Cheng He & Wen‐Juan Sun. (2018) Pioglitazone/metformin adduct regulates insulin secretion and inhibits high glucose‐induced apoptosis via p21‐p53‐MDM2 signaling in INS‐1 cells. Journal of Cellular Biochemistry 119:7, pages 5449-5459.
Crossref
Cheryl Neslusan, Anna Teschemaker, Michael Willis, Pierre Johansen & Lien Vo. (2018) Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States. Diabetes Therapy 9:2, pages 565-581.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.